# Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda

> **NCT01573754** · PHASE2 · COMPLETED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 48 (actual)

## Conditions studied

- Porphyria Cutanea Tarda

## Interventions

- **DRUG:** Hydroxychloroquine
- **PROCEDURE:** Phlebotomy

## Key facts

- **NCT ID:** NCT01573754
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03-21
- **Primary completion:** 2021-07-06
- **Final completion:** 2021-07-06
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01573754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01573754, "Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01573754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*